Creating new compounds to enhance DNA binding for disease treatment
Development of flavone- and flavonoid-based DNA triplex specific binding ligands as antigene enhancers
This study is exploring new compounds that can attach to a special form of DNA to help improve how genes work, with the hope of finding better treatments for diseases.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of the Pacific-Stockton NIH-funded |
| Lab location | 1 site (Stockton, United States) |
| Project ID | NIH-10579779 on NIH RePORTER |
What this research studies
This research focuses on developing new flavonoid-based compounds that can specifically bind to triplex DNA, which is a unique structure of DNA. By modifying these compounds and studying how they interact with DNA, researchers aim to create more effective agents that can enhance gene regulation and potentially treat diseases. The project involves synthesizing these compounds, analyzing their binding properties using advanced biophysical techniques, and understanding how they can inhibit certain enzymatic activities related to DNA. This work could lead to innovative therapeutic strategies that target genetic material directly.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with genetic disorders or diseases where gene regulation plays a critical role.
Not a fit: Patients with conditions unrelated to genetic regulation or those not affected by DNA-related disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that more effectively target and regulate genes involved in various diseases.
How similar studies have performed: While the approach of using flavonoid-based compounds for DNA binding is innovative, similar strategies in gene regulation have shown promise in other studies.
Where this research is happening
Stockton, United States
- University of the Pacific-Stockton — Stockton, United States (Active)
Researchers
- Principal investigator: Xue, Liang — University of the Pacific-Stockton
- Study coordinator: Xue, Liang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.